HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)
South Korea flag South Korea · Delayed Price · Currency is KRW
12,990
+420 (3.34%)
Oct 8, 2026, 10:50 AM KST

HLB Pharmaceutical Market Cap

HLB Pharmaceutical has a market cap or net worth of 426.06 billion as of October 7, 2026. That makes HLB Pharmaceutical the world's 18,288th most valuable company and 555th in South Korea. Its market cap has increased by 123.59% in one year.

Market Cap
426.06B
Enterprise Value
426.86B
Revenue
251.95B
Global Rank
Country Rank
#555 South Korea
PE Ratio
151.20

Chart

Chart

Since December 21, 2015, HLB Pharmaceutical's market cap has increased from 84.28B to 426.06B, an increase of 405.52%. That is a compound annual growth rate of 16.18%.

History

DateMarket Cap% Change
Oct 8, 2026426.06B89.16%
Dec 30, 2025225.24B-33.44%
Dec 30, 2024338.42B58.45%
Dec 28, 2023213.58B43.49%
Dec 29, 2022148.85B-21.48%
Dec 30, 2021189.57B-21.05%
Dec 30, 2020 Pro Pro
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding